FDA approves Wegovy to reduce heart attack and stroke risk
The U.S. Food and Drug Administration approved a label change that expands the use of the drug in Wegovy. It was previously approved to treat obesity.
← Back to stories
National19 articles from 13 sources across the spectrum· Updated 934d ago
7 across the spectrum · tap a section to jump
The story so far
2 developments- Mar 8, 2024FDA approves Wegovy to reduce heart attack and stroke risk
- Mar 9, 2024FDA approves Novo Nordisk drug Wegovy for use in lowering heart attack risks
Who covered each development
Left
Center
Right
No new developments
Quiet for 934 daysLast development · Mar 9, 2024 — FDA approves Novo Nordisk drug Wegovy for use in lowering heart attack risks
How each side is putting it
Left
2 viewpointsRan by 2 outlets· Portland Press Herald, Washington Post
FDA approves Wegovy for lowering heart attack and stroke risk in overweight patients
FDA approves Wegovy to reduce heart attack and stroke risk
Ran by 4 outlets across the spectrum· Quartz, Minneapolis Star Tribune
Center
3 viewpointsRan by 7 outlets· FOX 5 DC, FOX 35 Orlando, +5 more
Ran by 2 outlets· France 24, Digital Journal
Ran by 4 outlets across the spectrum· KOB 4, The Columbian
Right
2 viewpointsFDA approves Novo Nordisk drug Wegovy for use in lowering heart attack risks
Weight-loss drug Wegovy approved by FDA to cut heart attack, stroke risk